President Trump’s swift “On it” response to Scott Adams’ cancer treatment plea exposes how bureaucratic healthcare delays can threaten American lives while demonstrating the compassionate leadership our nation needs.
Story Highlights
- Trump immediately pledged help after Adams publicly revealed Kaiser Permanente’s scheduling delays.
- Adams faces declining health while waiting for approved Pluvicto cancer treatment.
- HHS Secretary RFK Jr. confirmed that the president would intervene in the healthcare bureaucracy.
- The case highlights systemic problems with managed care delaying critical treatments.
Presidential Intervention in Healthcare Crisis
President Donald Trump responded within hours to Dilbert creator Scott Adams’ desperate social media plea for help obtaining life-saving cancer treatment. Adams, battling metastatic prostate cancer, revealed that Kaiser Permanente had approved his Pluvicto treatment but failed to schedule the critical infusion.
“I am declining fast,” Adams wrote on X, explaining the treatment would give him “a fighting chance to stick around on this planet a little bit longer.” Trump’s immediate two-word response, “On it,” demonstrates decisive leadership when bureaucratic delays threaten American lives.
Trump responds to ‘Dilbert’ creator Scott Adams’ plea for help to obtain cancer treatment: ‘On it’ https://t.co/SiLDjei42J pic.twitter.com/dqGgXTW4ok
— New York Post (@nypost) November 3, 2025
Healthcare System Failures Exposed
Adams’ situation reveals troubling patterns within managed healthcare systems where administrative inefficiency can delay urgent medical care. Despite Kaiser Permanente’s claim of treating over 150 patients with Pluvicto in Northern California, the organization “dropped the ball” on scheduling Adams’ approved treatment.
The healthcare giant’s defensive statement about Adams’ oncology team working on “next steps” rings hollow when a patient faces declining health due to scheduling failures. This case exemplifies how centralized healthcare management can create dangerous bottlenecks that put patients’ lives at risk through bureaucratic incompetence.
Federal Leadership Steps In
Health and Human Services Secretary Robert F. Kennedy Jr. reinforced the administration’s commitment by publicly stating, “The President wants to help.” This coordinated federal response highlights the Trump administration’s willingness to cut through red tape when Americans face life-threatening delays.
Pluvicto, manufactured by Swiss drugmaker Novartis, reduces prostate cancer progression risk by 28% using radioactive particles that target tumors directly. The drug represents cutting-edge treatment that should be readily accessible to approved patients, not held up by administrative failures that could prove fatal.
Beyond Healthcare Reform
Adams has supported Trump consistently over recent years, weathering significant controversy, including newspaper boycotts following racially charged comments in 2023 that led to the widespread cancellation of his comic strip.
While Adams later characterized his remarks as hyperbole taken out of context, the incident effectively ended Dilbert’s decades-long run in the newspaper.
Despite past controversies, Trump’s response to Adams’ medical crisis demonstrates presidential leadership that transcends political considerations when American lives hang in the balance.
This intervention sends a clear message that healthcare bureaucracy should never supersede patient care, regardless of political affiliations or past missteps.
